134 related articles for article (PubMed ID: 23094579)
1. [Revival of selected well-tried antibiotics. Special features of the antiinfective agents penicillin G, fosfomycin, aztreonam and colistin].
Lipp HP
Med Monatsschr Pharm; 2012 Oct; 35(10):367-77. PubMed ID: 23094579
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.
Roussos N; Karageorgopoulos DE; Samonis G; Falagas ME
Int J Antimicrob Agents; 2009 Dec; 34(6):506-15. PubMed ID: 19828298
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of colistin: new insight into an old antibiotic.
Falagas ME; Rafailidis PI
Clin Infect Dis; 2009 Jun; 48(12):1729-31. PubMed ID: 19438398
[No Abstract] [Full Text] [Related]
4. Potential of old-generation antibiotics to address current need for new antibiotics.
Falagas ME; Grammatikos AP; Michalopoulos A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):593-600. PubMed ID: 18847400
[TBL] [Abstract][Full Text] [Related]
5. Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.
Poulakou G; Bassetti M; Righi E; Dimopoulos G
Future Microbiol; 2014; 9(9):1053-69. PubMed ID: 25340835
[TBL] [Abstract][Full Text] [Related]
6. Relative potency of different generic brands of meropenem, colistin and fosfomycin: Implications for antimicrobial therapy and antimicrobial formulary.
Das P; Jana B; Dhar K; Goel G; Bhattacharya S; Chandy M
Indian J Med Microbiol; 2019; 37(1):95-98. PubMed ID: 31424016
[TBL] [Abstract][Full Text] [Related]
7. 'Old' antibiotics for emerging multidrug-resistant bacteria.
Bergen PJ; Landersdorfer CB; Lee HJ; Li J; Nation RL
Curr Opin Infect Dis; 2012 Dec; 25(6):626-33. PubMed ID: 23041772
[TBL] [Abstract][Full Text] [Related]
8. Fosfomycin: Resurgence of an old companion.
Sastry S; Doi Y
J Infect Chemother; 2016 May; 22(5):273-80. PubMed ID: 26923259
[TBL] [Abstract][Full Text] [Related]
9. Colistin in the treatment of life-threatening infections.
Pavleas J; Skiada A; Daikos GL; Rigas K; Mega A; Archondoulis N; Vernikos P; Salatas K; Thomopoulos G
Int J Antimicrob Agents; 2006 Oct; 28(4):374-6. PubMed ID: 16963234
[No Abstract] [Full Text] [Related]
10. The revival of fosfomycin.
Michalopoulos AS; Livaditis IG; Gougoutas V
Int J Infect Dis; 2011 Nov; 15(11):e732-9. PubMed ID: 21945848
[TBL] [Abstract][Full Text] [Related]
11. [Role of the new beta lactams in severe infections. Imipenem and aztreonam: indications and limitations].
Sánchez C; Garau J
Enferm Infecc Microbiol Clin; 1989; 7 Suppl 1():67-75. PubMed ID: 2490491
[No Abstract] [Full Text] [Related]
12. Antimicrobial resistance of Acinetobacter spp. in Europe.
Falagas ME; Kasiakou SK; Michalopoulos A
Clin Microbiol Infect; 2004 Dec; 10(12):1106-7. PubMed ID: 15606642
[No Abstract] [Full Text] [Related]
13. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
[TBL] [Abstract][Full Text] [Related]
14. Colistin Use in Neonates and Children With Infections Due to Carbapenem-resistant Bacteria.
Antachopoulos C; Iosifidis E
Pediatr Infect Dis J; 2017 Sep; 36(9):905-907. PubMed ID: 28650936
[TBL] [Abstract][Full Text] [Related]
15. Fosfomycin for urinary tract infections.
Med Lett Drugs Ther; 1997 Jul; 39(1005):66-8. PubMed ID: 9255237
[No Abstract] [Full Text] [Related]
16. Other antibiotics.
Hayashi K
Clin Orthop Relat Res; 1984 Nov; (190):109-13. PubMed ID: 6386254
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity associated with intravenous colistin.
Tarchini G
Clin Infect Dis; 2009 Dec; 49(11):1773; author reply 1773. PubMed ID: 19891573
[No Abstract] [Full Text] [Related]
18. A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
Mangini P; Cicchetti M; Bottaro L; Messina V; Brancadoro MT; Puppo F
Chemioterapia; 1985 Jun; 4(3):222-6. PubMed ID: 4028283
[TBL] [Abstract][Full Text] [Related]
19. Intravenous fosfomycin for the treatment of hospitalized patients with serious infections.
Shorr AF; Pogue JM; Mohr JF
Expert Rev Anti Infect Ther; 2017 Oct; 15(10):935-945. PubMed ID: 28901793
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors of colistin-induced nephrotoxicity.
Kim J; Lee KH; Yoo S; Pai H
Int J Antimicrob Agents; 2009 Nov; 34(5):434-8. PubMed ID: 19726164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
